BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 12473174)

  • 1. Breast cancer incidence and mortality trends in an affluent population: Marin County, California, USA, 1990-1999.
    Clarke CA; Glaser SL; West DW; Ereman RR; Erdmann CA; Barlow JM; Wrensch MR
    Breast Cancer Res; 2002; 4(6):R13. PubMed ID: 12473174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for breast cancer in a population with high incidence rates.
    Wrensch M; Chew T; Farren G; Barlow J; Belli F; Clarke C; Erdmann CA; Lee M; Moghadassi M; Peskin-Mentzer R; Quesenberry CP; Souders-Mason V; Spence L; Suzuki M; Gould M
    Breast Cancer Res; 2003; 5(4):R88-102. PubMed ID: 12817999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort.
    Marshall SF; Clarke CA; Deapen D; Henderson K; Largent J; Neuhausen SL; Reynolds P; Ursin G; Horn-Ross PL; Stram DO; Templeman C; Bernstein L
    Breast Cancer Res; 2010; 12(1):R4. PubMed ID: 20064209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Ecological Evaluation of Vinyl Chloride Exposure and Liver Cancer Incidence and Mortality in Texas.
    Towle KM; Benson SM; Egnot NS; Marsh GM
    J Clin Transl Hepatol; 2021 Feb; 9(1):99-105. PubMed ID: 33604260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of Geographical Disparities: The Use of An Interpolation Method For Cancer Registry Data.
    Campbell JE; Sedani AE; Dao HDN; Sambo A; Doescher M; Janitz A
    J Okla State Med Assoc; 2023; 116(2):62-71. PubMed ID: 37408787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Absorbed Dose Estimation of
    Yousefnia H; Zolghadri S; Alirezapour B
    J Med Phys; 2022; 47(2):194-200. PubMed ID: 36212201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. County-level characteristics associated with incidence, late-stage incidence, and mortality from screenable cancers.
    Moss JL; Wang M; Liang M; Kameni A; Stoltzfus KC; Onega T
    Cancer Epidemiol; 2021 Dec; 75():102033. PubMed ID: 34560364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The virology of breast cancer: viruses as the potential causative agents of breast tumorigenesis.
    Lehrer S; Rheinstein PH
    Discov Med; 2019 Mar; 27(148):163-166. PubMed ID: 31095925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher Breast Cancer Risk Among Immigrant Asian American Women Than Among US-Born Asian American Women.
    Morey BN; Gee GC; von Ehrenstein OS; Shariff-Marco S; Canchola AJ; Yang J; Allen L; Lee SS; Bautista R; La Chica T; Tseng W; Chang P; Gomez SL
    Prev Chronic Dis; 2019 Feb; 16():E20. PubMed ID: 30767860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affluence and Breast Cancer.
    Lehrer S; Green S; Rosenzweig KE
    Breast J; 2016 Sep; 22(5):564-7. PubMed ID: 27296617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population.
    Jupe ER; Dalessandri KM; Mulvihill JJ; Miike R; Knowlton NS; Pugh TW; Zhao LP; DeFreese DC; Manjeshwar S; Gramling BA; Wiencke JK; Benz CC
    BBA Clin; 2014 Dec; 2():94-102. PubMed ID: 26673457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer.
    Koh CH; Bhoo-Pathy N; Ng KL; Jabir RS; Tan GH; See MH; Jamaris S; Taib NA
    Br J Cancer; 2015 Jun; 113(1):150-8. PubMed ID: 26022929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of very early breast cancer in a setting without organised screening.
    Bhoo-Pathy N; Subramaniam S; Taib NA; Hartman M; Alias Z; Tan GH; Ibrahim RI; Yip CH; Verkooijen HM
    Br J Cancer; 2014 Apr; 110(9):2187-94. PubMed ID: 24736587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing breast cancer risk models in Marin County, a population with high rates of delayed childbirth.
    Powell M; Jamshidian F; Cheyne K; Nititham J; Prebil LA; Ereman R
    Clin Breast Cancer; 2014 Jun; 14(3):212-220.e1. PubMed ID: 24461459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying risk factors for disparities in breast cancer mortality among African-American and Hispanic women.
    Tian N; Goovaerts P; Zhan FB; Chow TE; Wilson JG
    Womens Health Issues; 2012; 22(3):e267-76. PubMed ID: 22265181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of racial disparities in breast cancer mortality: does scale matter?
    Tian N; Goovaerts P; Zhan FB; Wilson JG
    Int J Health Geogr; 2010 Jul; 9():35. PubMed ID: 20602784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent trends in hormone therapy utilization and breast cancer incidence rates in the high incidence population of Marin County, California.
    Ereman RR; Prebil LA; Mockus M; Koblick K; Orenstein F; Benz C; Clarke CA
    BMC Public Health; 2010 Apr; 10():228. PubMed ID: 20433756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cluster morphology analysis.
    Jacquez GM
    Spat Spatiotemporal Epidemiol; 2009; 1(1):19-29. PubMed ID: 20234799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004.
    Keegan TH; Chang ET; John EM; Horn-Ross PL; Wrensch MR; Glaser SL; Clarke CA
    Breast Cancer Res; 2007; 9(5):R62. PubMed ID: 20210979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry.
    Kurian AW; Gong GD; John EM; Miron A; Felberg A; Phipps AI; West DW; Whittemore AS
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1084-91. PubMed ID: 19336551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.